MRSA Clinical Trial
Official title:
A Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy of Retapamulin as a Topical Decolonizing Agent for Mupirocin Resistant Methicillin Resistant Staphylococcus Aureus (MRSA)
The purpose of this study is to investigate the efficacy of retapamulin to reduce carriage of MRSA via a randomized, double-blind, placebo-controlled clinical study testing retapamulin among patients with confirmed mupirocin-resistant nasal and/or rectal MRSA colonization. The sample size will include 27 subjects in each of the two arms of the study (retapamulin versus placebo) for a total of 54 subjects. Participants who are found to be nasal and/or rectal colonized with MRSA will be randomized to receive either retapamulin or placebo applied nasally and rectally for a total of 5 days. Nasal and rectal swabs will be collected at pre-defined time points during study duration (screening swab, swab one week after completion of topical therapy, swab 4 weeks after completion of topical therapy) to assess MRSA colonization status. The colonization rates of both groups will be assessed via Fisher's Exact Test.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03181932 -
AeroVanc in the Treatment of Methicillin-resistant Staphylococcus Aureus Infection in Patients With Cystic Fibrosis
|
Phase 3 | |
Completed |
NCT03268122 -
Comparison of Standard Isolation With Targeted Isolation for Preventing Nosocomial Transmission of MRSA and VRE
|
N/A | |
Completed |
NCT04312776 -
Tracing MRSA in Households With Patients Infected With CA-MRSA by WGS
|
||
Recruiting |
NCT04104178 -
Optimal Treatment of MRSA Throat Carriers
|
Phase 3 | |
Recruiting |
NCT04793152 -
Vancomycin Dosing for Serious MRSA Infections: A Non-inferiority Randomized Trial of Trough Level Versus AUC/MIC
|
N/A | |
Completed |
NCT03601741 -
Use of Disposable Stethoscope Covers for Reduction of Stethoscope MRSA Contamination
|
N/A | |
Completed |
NCT02690415 -
Community-Assoc. S. Aureus Colonization and Recurrent Infection in Pts With Uncomplicated S. Aureus Skin Abscesses
|
||
Enrolling by invitation |
NCT04297592 -
Antibiotic Prophylaxis in High-Risk Arthroplasty Patients
|
Phase 4 | |
Recruiting |
NCT05268120 -
MRSA Decolonization in Complicated Carriage
|
N/A | |
Completed |
NCT01167452 -
Effect of Weight and/or Obesity on Sulfamethoxazole and Trimethoprim Concentrations
|
Phase 4 | |
Recruiting |
NCT04083092 -
Surveillance of Community-Associated MRSA
|
||
Recruiting |
NCT02443064 -
Pharmacokinetics/ Pharmacodynamics (PK/PD) Study of Vancomycin
|
Phase 4 | |
Completed |
NCT02029872 -
Stop Community MRSA Colonization Among Patients
|
Phase 4 | |
Not yet recruiting |
NCT05696132 -
Evaluation of the Decolonization Rate and Acceptance of a Complete Nasal Decolonization Kit With Povidone Iodine for MRSA Patients
|
Phase 2 | |
Recruiting |
NCT02127658 -
MRSA Eradication and Decolonization in Children
|
N/A | |
Completed |
NCT00822276 -
The Underlying Mechanisms For S. Aureus Infection And Colonization Of Skin in People With Atopic Dermatitis With And Without Eczema Herpeticum (MRSA)
|
N/A | |
Withdrawn |
NCT02547116 -
Epidemiology and Treatment of Small-colony Variant Staphylococcus Aureus in Cystic Fibrosis
|
Phase 4 | |
Completed |
NCT01318213 -
Benefits of Universal Glove and Gowning
|
||
Enrolling by invitation |
NCT05395520 -
Vancomycin Monitoring: Is AUC Monitoring Appropriate for More Than Just Serious MRSA Infections?
|